2-fluoro-5-(2-methyl-[1,3]dioxolan-2-yl)-benzenesulfonamide → 5-(2-Bromomethyl-[1,3]dioxolan-2-yl)-2-fluoro-benzenesulfonamide
Reaction equation
[Br-:1].[Br-].[Br-].C1([N+](C)(C)C)C=CC=CC=1.C1([N+](C)(C)C)C=CC=CC=1.C1([N+](C)(C)C)C=CC=CC=1.[F:34][C:35]1[CH:40]=[CH:39][C:38]([C:41]2([CH3:46])[O:45][CH2:44][CH2:43][O:42]2)=[CH:37][C:36]=1[S:47]([NH2:50])(=[O:49])=[O:48]>CC#N>[Br:1][CH2:46][C:41]1([C:38]2[CH:39]=[CH:40][C:35]([F:34])=[C:36]([S:47]([NH2:50])(=[O:49])=[O:48])[CH:37]=2)[O:45][CH2:44][CH2:43][O:42]1Participants
4
Procedure
A solution of 8.4 g (0.0225 mole) of phenyltrimethylammonium tribromide in 20 mL of CH3CN was added dropwise to a solution of 5.2 g (0.022 mole) 2-fluoro-5(2-methyl-[1,3]dioxolan-2-yl)-benzenesulfonamide III in 100 mL of CH3CN. The reaction was stirred at room temperature for 1 hr. The solvent was evaporated in vacuo. The residue was dissolved in EtOAc, washed with water, dried over Na2SO4 and evaporated. The residue was purified by column chromatography on silica gel eluting with CH2Cl2/Et2O::9/1 to give 4.6 g of IV (62%) as an oil. CH2Cl2/Et2O::9/1 single-spot material Rƒ 0.30.1H NMR (300 MHz CDCl3) δ: (3.68, s, 2H), (3.80,m , 2H), (4.21, m, 2H), 5.15, broad s, 2H), (7.26, t, 1H), (7.75, m, 1H), 8.15, dd, 1H).
Workup
- customThe solvent was evaporated in vacuo
- dissolutionThe residue was dissolved in EtOAc
- washwashed with water
- dry with materialdried over Na2SO4
- customevaporated
- customThe residue was purified by column chromatography on silica gel eluting with CH2Cl2/Et2O
Sources & evidence
- ORD record
- ord-8a3e9eafd05846499fd43910bc549e9c
- Source dataset
- uspto-grants-2002_10
- Patent number
- US06461822B2
Reaction notes
Loading…